WESPAC Advisors’s Idexx Laboratories IDXX Stock Holding History

WESPAC Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-776	Closed	-$511K	–	121
2021 Q4	$511K	Buy	776 +57	+8%	+$35.8K	0.34%	97
2021 Q3	$447K	Buy	+719	New	+$483K	0.28%	111
2021 Q2	–	Sell	-741	Closed	-$363K	–	119
2021 Q1	$363K	Buy	741 +26	+4%	+$13K	0.27%	101
2020 Q4	$357K	Buy	+715	New	+$320K	0.28%	95
2018 Q4	–	Sell	-1,144	Closed	-$286K	–	134
2018 Q3	$286K	Buy	+1,144	New	+$278K	0.17%	116

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

WESPAC Advisors's IDXX Position: Q1 2022 in Review

WESPAC Advisors sold out of Idexx Laboratories (IDXX) in Q1 2022, closing a stake of 776 shares — an estimated $511K sold.

WESPAC Advisors first reported a position in IDXX in Q3 2018 and held it in 5 quarters. The position peaked at $511K in Q4 2021. 1,032 funds tracked by Wall St. Rank hold IDXX as of Q1 2022.

WESPAC Advisors reported no remaining Idexx Laboratories position as of Q1 2022 after selling out during the quarter.
WESPAC Advisors sold 776 Idexx Laboratories shares in Q1 2022, an estimated $511K.
WESPAC Advisors first reported a position in Idexx Laboratories in Q3 2018 and held it in 5 quarters.
WESPAC Advisors's Idexx Laboratories position peaked at $511K in Q4 2021.
1,032 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2022.

Based on WESPAC Advisors's 13F filing for Q1 2022, filed 27 Apr 2022.